Drug Story cover image

Ozempic & Obesity

Drug Story

00:00

Novo Nordisk pursues obesity market

Thomas describes Novo Nordisk's strategy to reframe obesity and test semaglutide for weight management.

Play episode from 38:55
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app